Suppr超能文献

人因子VIIa丝氨酸蛋白酶结构域中的高亲和力Ca(2+)结合位点及其在组织因子结合和催化活性形成中的作用。

High affinity Ca(2+)-binding site in the serine protease domain of human factor VIIa and its role in tissue factor binding and development of catalytic activity.

作者信息

Sabharwal A K, Birktoft J J, Gorka J, Wildgoose P, Petersen L C, Bajaj S P

机构信息

Department of Medicine, St. Louis University School of Medicine, Missouri 63104, USA.

出版信息

J Biol Chem. 1995 Jun 30;270(26):15523-30. doi: 10.1074/jbc.270.26.15523.

Abstract

Factor VIIa, in the presence of Ca2+ and tissue factor (TF), initiates the extrinsic pathway of blood coagulation. The light chain (amino acids 1-152) of factor VIIa consists of an N-terminal gamma-carboxyglutamic acid (Gla) domain followed by two epidermal growth factor-like domains, whereas the heavy chain (amino acids 153-406) contains the serine protease domain. In this study, both recombinant factor VIIa (rVIIa) and factor VIIa lacking the Gla domain were found to contain two high-affinity (Kd approximately 150 microM) Ca2+ binding sites. The rVIIa also contained approximately 6-7 low-affinity (Kd approximately 1 mM) Ca(2+)-binding sites. By analogy to other serine proteases, one of the two high affinity Ca(2+)-binding sites in factor VIIa may be formed involving Glu-210 and Glu-220 of the protease domain. In support of this, a synthetic peptide composed of residues 206-242 of factor VIIa bound one Ca2+ with Kd approximately 230 microM; however, Ca2+ binding was observed only in Tris buffer (pH 7.5) containing 1 M NaCl and not in buffer containing 0.1 M NaCl. In both low or high salt +/- Ca2+, the peptide existed as a monomer as determined by sedimentation equilibrium measurements and had no detectable secondary structure as determined by CD measurements. This indicates that subtle changes undetectable by CD may occur in the conformation of the peptide that favor calcium binding in high salt. In the presence of recombinant TF and 5 mM Ca2+, the peptide inhibited the amidolytic activity of rVIIa toward the synthetic substrate, S-2288. The concentration of the peptide required for half-maximal inhibition was approximately 5-fold higher in the low salt buffer than that in the high salt buffer. From direct binding and competitive inhibition assays of active site-blocked 125I-rVIIa binding to TF, the Kd for peptide-TF interaction was calculated to be approximately 15 microM in the high salt and approximately 55 microM in the low salt buffer containing 5 mM Ca2+. Moreover, as inferred from S-2288 hydrolysis, the Kd for VIIa.TF interaction was approximately 1.5 microM in the absence of Ca2+, and, as inferred from factor X activation studies, it was approximately 10 pM in the presence of Ca2+. Thus, Ca2+ decreases the functional Kd of VIIa.TF interaction approximately 150,000-fold.(ABSTRACT TRUNCATED AT 400 WORDS)

摘要

在钙离子(Ca2+)和组织因子(TF)存在的情况下,凝血因子VIIa启动血液凝固的外源性途径。凝血因子VIIa的轻链(氨基酸1 - 152)由一个N端γ-羧基谷氨酸(Gla)结构域和随后的两个表皮生长因子样结构域组成,而重链(氨基酸153 - 406)包含丝氨酸蛋白酶结构域。在本研究中,发现重组凝血因子VIIa(rVIIa)和缺乏Gla结构域的凝血因子VIIa均含有两个高亲和力(解离常数Kd约为150微摩尔)的Ca2+结合位点。rVIIa还含有约6 - 7个低亲和力(Kd约为1毫摩尔)的Ca(2+)结合位点。与其他丝氨酸蛋白酶类似,凝血因子VIIa中两个高亲和力Ca(2+)结合位点之一可能由蛋白酶结构域的Glu - 210和Glu - 220形成。支持这一观点的是,由凝血因子VIIa的206 - 242位残基组成的合成肽结合一个Ca2+,其Kd约为230微摩尔;然而,仅在含有1 M NaCl的Tris缓冲液(pH 7.5)中观察到Ca2+结合,而在含有0.1 M NaCl的缓冲液中未观察到。通过沉降平衡测量确定,在低盐或高盐±Ca2+条件下,该肽均以单体形式存在,通过圆二色性(CD)测量确定其没有可检测到的二级结构。这表明在高盐条件下,肽的构象可能发生CD检测不到的细微变化,有利于钙结合。在重组TF和5 mM Ca2+存在的情况下,该肽抑制rVIIa对合成底物S - 2288的酰胺水解活性。在低盐缓冲液中,达到半数最大抑制所需的肽浓度比在高盐缓冲液中高约5倍。通过活性位点封闭的125I - rVIIa与TF结合的直接结合和竞争性抑制试验,计算出在高盐缓冲液中肽与TF相互作用的Kd约为15微摩尔,在含有5 mM Ca2+的低盐缓冲液中约为55微摩尔。此外,从S - 2288水解推断,在无Ca2+时VIIa.TF相互作用的Kd约为1.5微摩尔,从因子X激活研究推断,在有Ca2+时约为10皮摩尔。因此,Ca2+使VIIa.TF相互作用的功能Kd降低约150,000倍。(摘要截断于400字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验